Rates and risk factors for major adverse cardiovascular and cerebrovascular events after stroke due to intracerebral hemorrhage: Systematic review and study-level meta-analysis
Authors:
- Vega Pratiwi PutriVPVega Pratiwi Putri
- Neshika SamarasekeraNSNeshika Samarasekera
- Tom J MoullaaliTMTom J Moullaali
- Joseph AkedJAJoseph Aked
- Signild ÅsbergSÅSignild Åsberg
- Sam SchulmanSSSam Schulman
- Georgios TsivgoulisGeorgios Tsivgoulis
- Maria PikilidouMPMaria Pikilidou
- Hsin-Hsi TsaiHTHsin-Hsi Tsai
- Phyo Kyaw MyintPMPhyo Kyaw Myint
Open Access
- 25 February 2026
- journal article
- review article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (6) , 778-787
Abstract
Background: Intracerebral hemorrhage (ICH) survivors are at increased risk of major adverse cardiovascular and cerebrovascular events (MACE) compared with population controls; however, little is known about the annual rates and risk factors for MACE. Methods: We searched Medline, Embase, and trial registries systematically in April 2024 for studies of adults with ICH, reporting either a MACE composite outcome or both ischemic and hemorrhagic outcomes, with at least one year of follow-up. We excluded studies limited to secondary ICH or isolated non-ICH intracranial hemorrhages. We used the QUIPS tool to assess studies’ risk of bias. The primary outcome was the rate of MACE. We used a random-effects meta-analysis to estimate the annual event rate (per 100 person-years, expressed as %) for each outcome. We conducted subgroup analyses and meta-regression to explore heterogeneity. Results: We included 26 studies, involving 198,289 ICH survivors. Individual studies’ reported annual rate of MACE ranged 4.2–14.6%. The pooled annual rate of recurrent ICH was 2.1% (95% confidence interval (CI) = 1.7–2.6; 26 studies; I 2 = 94%) and of ischemic stroke was 2.0% (95% CI = 1.5–2.7; 24 studies; I 2 = 95%). Meta-regression analyses identified one statistically significant association between a higher prevalence of atrial fibrillation and an increased risk of ischemic stroke. Discussion: The rates of recurrent ICH and ischemic stroke were comparable among ICH survivors, but evidence about other MACE outcomes remains limited. An individual participant data meta-analysis is needed to investigate the predictors of MACE outcomes, which may help inform risk stratification and prognosis among ICH survivors.Keywords
Funding Information
- Indonesian Endowment Fund for Education (20230722299248)
This publication has 46 references indexed in Scilit:
- Major Cardiovascular Events After Spontaneous Intracerebral Hemorrhage by Hematoma LocationJAMA Network Open, 2023
- Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular EventsJAMA Network Open, 2022
- Clinical effects of restarting antiplatelet therapy in patients with intracerebral hemorrhageClinical Neurology and Neurosurgery, 2022
- Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral HemorrhageJAMA Neurology, 2021
- Association Between Intracerebral Hemorrhage and Subsequent Arterial Ischemic Events in Participants From 4 Population-Based Cohort StudiesJAMA Neurology, 2021
- Low-dose antiplatelet therapy survey after intracerebral hemorrhage in China: a retrospective hospital-based studyNeurosurgical Review, 2021
- Acute hematoma expansion after spontaneous intracerebral hemorrhage: risk factors and impact on long-term prognosisNeurological Sciences, 2020
- Stroke recurrence and mortality in northeastern Greece: the Evros Stroke RegistryJournal of Neurology, 2018
- Meta-Analysis with R2015
- Leukoaraiosis is Associated with Short- and Long-term Mortality in Patients with Intracerebral HemorrhageJournal of Stroke and Cerebrovascular Diseases, 2013